Ficolins are soluble molecules that bind carbohydrate present on the surface of microorganisms and function as recognition molecules in the lectin complement pathway. Three ficolins have been identified in humans: ficolin-1, ficolin-2, and ficolin-3. Ficolin-1 is synthesized in monocytes and type II alveolar epithelial cells. Ficolin-1 has been shown to be present in secretory granules of human neutrophils, but it is not known which subset of the neutrophils' secretory granules harbors ficolin-1. To determine the exact subcellular localization of ficolin-1 in neutrophils, recombinant ficolin-1 was expressed in Chinese hamster ovary cells and used for generation of polyclonal antibodies. This allowed detection of ficolin-1 in subcellular fractions of human neutrophils by ELISA, by Western blotting, and by immunohistochemistry. Real-time PCR examination of normal human bone marrow showed FCN1 gene expression largely in myelocytes, metamyelocytes, and band cells with a profile quite similar to that of gelatinase. In accordance with this, biosynthesis studies of neutrophils precursor cells showed that ficolin-1 was primarily synthesized in myelocytes, metamyelocytes, and band cells. Immunohistochemistry and subcellular fractionation demonstrated that ficolin-1 is primarily localized in gelatinase granules but also in highly exocytosable gelatinase-poor granules, not described previously. Ficolin-1 is released from neutrophil granules by stimulation with fMLP or PMA, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry. Our studies show that neutrophils are a major source of ficolin-1, which can be readily exocytosed by stimulation.
Introduction
PRMs participate in innate immune defense by facilitating engulfment and killing of intruding microorganisms [1, 2] . PRMs exist both as membrane-bound proteins, such as the TLRs [3] , and as soluble proteins such as mannose-binding lectin [4] , surfactant protein A and D [5] , and ficolins [6] . Three different forms of ficolins have been identified in man: ficolin-1 (Mficolin), ficolin-2 (L-ficolin), and ficolin-3 (H-ficolin/ Hakata antigen). All three can be detected in plasma [7] [8] [9] . Ficolins are homopolymeric molecules, each consisting of subunits of three identical polypeptides containing an N-terminal collagen-like domain and a carbohydrate-recognizing C-terminal fibrinogen-like domain [10] . Ficolins bind acetylated sugar molecules and other molecular structures present on the surface of microorganisms [11] and can associate with MASPs, the complement-activating serine proteases, initially found to be associated with mannose-binding lectin [11, 12] . Ficolin-2 is synthesized in the liver, while ficolin-3 is synthesized in the liver and lungs [13, 14] . Of the three ficolins, ficolin-1 has been the least studied. Ficolin-1 has been shown to be synthesized by monocytes and type II alveolar epithelial cells [14] and is expressed from the FCN1 gene on chromosome 9 [14] . FCN1 transcript was recently shown to be present in the terminal stages of neutrophil differentiation in normal human bone marrow [15] , and the protein was shown to be present in secretory granules of neutrophils [12, 16] . Neutrophil granules encompass at least three major types: azurophil granules, specific granules, and gelatinase granules with major differences in their propensity for exocytosis and thus in their biological function [17] .
Since targeting of granule proteins to particular granular subsets of neutrophils is determined by the time of their ex-pression in neutrophil precursors in the bone marrow [18, 19] , expression of FCN1 during myelopoiesis was determined by quantitative real-time PCR and synthesis of ficolin-1 in myeloid precursors was studied by radioactive pulse and chase followed by immunoprecipitation. Immunohistochemistry and subcellular fractionation were performed, and surface expression of the protein was analyzed by flow cytometry, to determine the subcellular localization of ficolin-1 in human neutrophils.
MATERIALS AND METHODS

Isolation of neutrophils
Neutrophils were isolated from peripheral blood drawn from healthy adult donors after informed consent was obtained. The study was approved by the local ethics committee. The cells were isolated by density centrifugation and subsequent hypotonic lysis of the erythrocytes, as described previously [20] .
Stimulation of neutrophils
Isolated neutrophils (7.5-9ϫ10 8 ) were resuspended at 3 ϫ 10 7 cells/ml in KRP (130 mM NaCl, 5 mM KCl, 1.27 mM MgCl 2 , 0.95 mM CaCl 2 , 10 mM NaH 2 PO 4 /Na 2 HPO 4 , pH 7.4) buffer containing 5 mM glucose. The cell suspension was divided in three batches. One was kept at 4°C, the remaining two were preincubated at 37°C for 5 min followed by 15 min of stimulation with either 10 Ϫ8 M fMLP (Sigma Chemical, St. Louis, MO, USA) or 100 ng/ml PMA (Sigma Chemical). Two volumes of ice-cold KRP were added to stop the stimulation, and the cells were then pelleted by centrifugation at 200 g for 6 min. The supernatant (S 0 ) was aspirated and kept for later analysis. The pellets were resuspended at 3 ϫ 10 7 cells/ml in KRP and treated with 5 mM diisopropylfluorophosphate (Calbiochem, Damstadt, Germany) for 5 min to inhibit serine proteases. The cells were centrifuged at 200 g for 6 min. The supernatant was removed, and each pellet was resuspended at 3ϫ10 7 cells/ml in disruption buffer (100 mM KCl, 3 mM NaCl, 1 mM Na 2 ATP, 3.5 mM MgCl 2 , 10 mM PIPES, pH 7.2) ϩ 0.5 mM PMSF (Sigma Chemical) for disruption by nitrogen cavitation [20] .
Subcellular fractionation of neutrophils
Subcellular fractionation of neutrophils was performed by nitrogen cavitation and sedimentation of the postnuclear supernatant (S 1 ) on a 3-layer Percoll density gradients, as described previously [21] .
After centrifugation, the gradients contained four major bands: the ␣-band containing azurophil granules, the ␤ 1 -band containing specific granules, the ␤ 2 -band containing gelatinase granules, and ␥-band containing secretory vesicles and cell membranes. Fractions of 1 ml each were collected at 4°C by aspiration from the bottom of the gradient using a fraction collector. MPO, NGAL, gelatinase, HSA, and HLA were measured in each fraction by ELISA and used as marker proteins for azurophil granule, specific granules, gelatinase granules, secretory vesicles, and cell membrane, respectively, as described previously [22] .
FACS analysis on stimulated neutrophils
Neutrophils were isolated as described above and divided into a control batch and a batch for stimulation. Stimulation with 10 Ϫ8 M fMLP was performed as described above. The neutrophils were then resuspended at 1ϫ10 6 cells/ml in PBS containing 0.5% BSA. 1.5ϫ10 5 unstimulated cells or and equal amounts of stimulated cell were incubated with either 100 g/ml monoclonal anti-r-ficolin-1, 10 g/ml mouse IgG 1 were incubated with 5 g recombinant ficolin-1 for 30 min and subsequently with 100 g/ml monoclonal anti-r-ficolin-1 for 30 min at 4°C. Cells marked with unlabeled antibodies were resuspended in 150 l PBS/BSA and incubated with 10 g/ml secondary polyclonal-goat-anti-mouse IgG-FITC/goat F(ab) 2 (REF: F0479 , Elektra box, Krokstadelva, Norway) for 30 min at 4°C. The cells were then washed twice, resuspended in 400 l PBS, and analyzed on a FACS Calibur (Becton Dickinson) for expression of ficolin-1, HLA, and CD11b on the cell surface.
Generation of rFCN1
The human FCN1 gene was amplified tagged with a hexa-His sequence in the C-terminal end using forward primer 5Ј-ctagtctagagcgagatggagctgagtggagcca-3Ј and reverse primer 5Ј-accggaattccgctaatggtgatggtgatgatgggcgggccgcaccttca-3Ј essentially as described previously for production of recombinant ficolin-2 [23] . The construct was cloned into an expression vector and transfected into a Chinese hamster ovary (CHO) cell line (DG44). Subsequently, recombinant ficolin-1 was purified from CHO cell supernatant using a TALON metal affinity resin column (Clontech, Palo Alto, CA, USA), and eluted with 100 mM imidazole.
Generation of polyclonal rabbit antibodies against human ficolin-1
Recombinant ficolin-1 was injected into rabbits for immunization. Immunization and venesections were performed by Dako (Glostrup, Denmark). IgG was eluted from the rabbit serum using a protein-A column. Briefly, the protein-A column was washed in 10 ml buffer A (50 mM Tris, 3 M NaCl, pH 8.6). Antiserum was diluted 1:3 in buffer P (50 mM Tris, 4 M NaCl, pH 8.6), filtered and applied to the column. After washing with 10 ml of buffer A, IgG was eluted with 3 M KSCN and dialyzed against PBS. Finally, 0.1% Na-azide was added.
ELISA
An ELISA for ficolin-1 was developed using 96-well flat-bottomed immunoplates (Nunc, Roskilde, Denmark). All steps were performed at room temperature. The wells were coated overnight with 100 l rabbit anti-ficolin-1 diluted 1:1600 in carbonate buffer (50 mM Na 2 CO 3 /NaHCO 3 , pH 9,6). The plates were washed three times in washing buffer (0.5 M NaCl, 3 mM KCl, 8 mM Na 2 HPO 4 /KH 2 PO 4 , 1% Triton X-100, pH 7.2) using a SkanWasher (Skatron, Roskilde, Denmark). Additional binding sites were blocked by incubation with 200 l/well dilution buffer (0.5 M NaCl, 3 mM KCl, 8 mM Na 2 HPO 4 /KH 2 PO 4 , 1% BSA, 1% Triton X-100, pH 7.2) for 1 h and washed as described above. All subsequent incubations were performed for 1 h followed by washing three times. Additions were made in 100 l/well. Ficolin-1 standards (range: 0.08 ng/ml to 5 ng/ml) and samples were diluted in dilution buffer. Biotinylated rabbit anti-ficolin-1 diluted 1:500 in dilution buffer was added followed by incubation with Avidin/HRP diluted 1:5000 in dilution buffer. The plates were then preincubated with substrate buffer (0.1 M sodium phosphate, 0.1 M citric acid, pH 5.0) for 5 min. Substrate buffer containing 0.04% OPD (Orhto-PhenyleneDiamine, Kem-En-Tec, Taastrup, Denmark), and 0.006% H 2 O 2 was then added. After ϳ15 min of incubation, the color reaction was stopped by adding 100 l/well 1 M H 2 SO 4 . Absorbance was read at 492 nm in a Multiscan Ascent ELISA reader (Labsystems, Helsinki, Finland). GlyNac (200 mM; Sigma Chemical) was added to samples containing DNA to prevent ficolin-1 from being trapped in the granule debris that was removed from samples prior to assay.
SDS-PAGE and immunoblotting
Samples for SDS-PAGE were dissolved in Laemmli sample buffer [24] , under reducing conditions, using mercaptoethanol as a reducing agent, or nonreducing conditions and run on 12% polyacrylamide gels using a Bio-Rad Mini Protean 3 cell (Bio-Rad Laboratories, Munich, Germany). Proteins were transferred to nitrocellulose using Bio-Rad Mini Trans-Blot Module (Bio-Rad). Additional binding sites were blocked by incubation in 5% skim milk/PBS for 1 h. The blots were washed three times with PBS/ 0.5% BSA and incubated overnight with anti-ficolin-1 diluted 1:1000 in PBS/0.5% BSA, followed by a 2 h incubation with HRP-swine anti-rabbit Ig (Dako) diluted 1:1000 in PBS/0.5% BSA. Finally, the blots were washed 3 times in PBS/0.5% BSA and once in PBS/0.05% Tween 20. Luminescence was induced using SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL, USA), according to the manufacturers' instructions and analyzed on a Bio-Rad Chemidoc (Bio-Rad).
Immunohistochemistry
Immunohistochemistry was performed as described previously [25, 26] . In brief, neutrophils were isolated as described above and resuspended at 2 ϫ 10 6 cells/ml in 50 mM phosphate buffer/1% paraformaldehyde for fixation overnight at 4°C. Cytospins with 2 ϫ 10 5 cells per poly-L-lysine-coated slide were permeabilized in TBS/1% Triton X-100 ϩ 1% BSA for 30 min and preblocked in TBS containing 10% normal goat serum and 0.25% BSA for 30 min at room temperature. The cytospins were then exposed to primary antisera diluted in TBS/10% goat serum ϩ 0.3% Triton X-100 ϩ 0.25% BSA overnight at 4°C. Following washing, the site of antigen-antibody reaction was revealed with fluorescence-labeled second antibodies. Sections were reacted with either rabbit anti-gelatinase, anti-MPO, or anti-hCAP18 at 0.5 g/ml, using detection with Alexa594-labeled goat-anti-rabbit Ig at 0.5 g/ ml. Subsequently, sections were treated with 50 mM phosphate buffer/1% paraformaldehyde for 45 min at room temperature to covalently attach the antibodies to the sections. Reactive IgG sites were then destroyed by microwaving at full strength in 0.06 M sodium citrate buffer pH 6.0 for 3 times 5 min. After renewed preblocking with TBS/10% goat serum ϩ 0.25% BSA, sections were reacted with rabbit anti-ficolin-1 antibody at 0.5 g/ml, using detection with Alexa 488-labeled second antibodies at 0.5 g/ml. Controls consisted of conventional staining controls [27] , as well as of preabsorption of the ficolin-1 antibody with recombinant ficolin-1 (data not shown). Omissions of the respective primary antibodies in the double-staining protocols attested that there was no crosstalk in the procedures. Images were acquired as optical sections (focusing series) in a Leica AF6000LX microscope equipped with software for deconvolution.
Isolation of bone marrow neutrophil precursor cells for real-time-PCR
Bone marrow was obtained from volunteering healthy donors giving informed consent. The study was approved by the local ethics committee. The posterior superior iliac crest was punctured under local anesthesia, and 15 ml marrow was aspirated into 5 ml of ACD (0.8% citric acid monohydrate, 2.2% Tri-Na citrate dihydrate, 2.7% glucose monohydrate) and mixed with 20 ml 2% dextran T500 in 0.9% saline to sediment erythrocytes. The leukocyte-rich supernatant was centrifuged at 200 g for 10 min. This and all subsequent steps were performed at 4°C. The cell pellet was resuspended in 45 ml PBS. Five two-layer Percoll gradients containing 2 ϫ 9 ml Percoll with the density of 1.065 g/ml and 1.080 g/ml were overlayered with a 9-ml cell suspension and centrifuged as described previously [28] . Three major bands of cells were aspirated separately: Band 3, containing myeloblasts (MB) and promyelocytes (PM), band 2 containing myelocytes (MC) and metamyelocytes (MM), and band 1 containing band cells (BC), and segmented cells (SC). Band 1 was subjected to hypotonic lysis for 30 s to remove the remaining erythrocytes. The cells in the three bands were subjected to immunomagnetic (MACS) depletion for removal of nongranulocytic cells, as described previously [29] . Band 3 was incubated for 15 min. with monoclonal mouse-antibodies against CD2, CD3, CD10, CD11b, CD14, CD16, CD19, CD56, CD61, and glycophorin A. Band 2 and band 1 were incubated with monoclonal mouse-antibodies against the same surface antigens as band 3 with the exceptions of CD11b in band 2 and CD3, CD10, CD11b, and CD16 in band 1. In addition, band 1 was incubated with antibody against CD49d. The cells were then washed twice and resuspended in ice-cold MACS-buffer (PBS, 0.5% BSA, 2 mM EDTA, pH 7.2) for incubation with anti-mouse IgG 1 -and IgG 2A-2B MACS beads for 15 min [29] . After an additional wash, the cells were resuspended in MACS buffer and subjected to depletion in MidiMACS LD columns (Miltenyi Biotec, Bergisch Gladbach, Germany), according to the manufacturer's instructions. Finally, the cells were collected and counted, and cytospins were made to verify the quality of the separation of immature granulocytes, according to their stage of maturation.
RNA isolation and cDNA synthesis
Cells from each band were pelleted and resuspended in 1 ml TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) for RNA isolation, according to the manufacturer's instructions. After air-drying, the RNA pellet was resuspended in 0.1 mM EDTA, and the amount of RNA was measured by spectrophotometry. Reverse transcription of RNA to first-strand cDNA was performed on 1 l RNA from each cell population to be examined diluted in 10 l DEPC-treated water. 1 l 50 M random hexamer primers (Invitrogen) were added. The solution was denatured at 70°C for 10 min followed by addition of 4 l 5ϫ first-strand buffer (Promega, Madison, WI, USA), 1 l 10 mM dNTP, 1 l RNAsin (Invitrogen), 2 l 0.1 M DTT (Promega), and 1 l Superscript II Reverse Transcriptase (Invitrogen). The conditions for RT included 22°C for 10 min, 45°C for 45 min, and 98°C for 5 min.
Real-time PCR
Real-time PCR was performed in triplicate using 5 l cDNA diluted 1:40 in DEPC-treated water, 5 l TaqMan Universal PCR Master mix (Applied Biosystems, Foster City, CA, USA), and 0.5 l TaqMan Gene Expression Assay (ABI) specific for the mRNA to be detected; FCN1 (Assay ID HS00157572_m1), MPO (Assay ID HS00165162_m1), NGAL (Assay ID HS00194353_m1), gelatinase (Assay ID HS00234578), and ␤-actin (Assay ID HS99999903_m1). Reaction conditions included incubation at 95°C for 10 min. followed by 40 cycles at 95°C for 30 s, 55°C for 1 min and 72°C for 30 s. The amount of fluorescent (FAM) was measured at the end of each cycle.
Triton X-114 phase separation
Triton X-114 phase separation was performed essentially as described by Bordier [30] . A ␤-band from neutrophils was solubilized in 0.7% Triton X-114, 100 mM NaCl, 10 mM Tris, pH 7.4 at 4°C. Membrane material was removed by centrifugation at 30,000 rpm for 20 min at 4°C. The supernatant was heated to 37°C for 20 min, and Triton X-114 separation was performed by centrifugation at 1500 g for 20 min at 37°C. The Triton X-114-rich pellet was diluted to the initial volume in 100 mM NaCl, 10 mM Tris, pH 7.4. The Triton X-114-poor supernatant, and the resuspended Triton X-114-rich pellet were mixed with SDS sample buffer and analyzed by SDS-PAGE and immunoblotting as described above using primary rabbitanti-Ficolin-1, rabbit-anti-hCAP-18, and mouse-anti-NGAL. Luminescence was detected using secondary swine-anti-rabbit-HRP (REF: 
Release of ficolin-1 from neutrophils stimulated with fMLP
Neutrophils were isolated and stimulated with fMLP as described above. The cells were pelleted and lysed at 3 ϫ 10 7 cells/ml in lysis buffer. The amount of ficolin-1, gelatinase, and HSA in cell lysate and S 0 were measured by ELISA.
(Gibco-BRL, Meda NS, Herlev, Denmark) containing 100 U/& penicillin, 100 pg/ml streptomycin, and 10% dialyzed FCS (Gibco-BRL), and incubated for 30 min at 37°C. The cells were subsequently pelleted by centrifugation, resuspended at 3 ϫ 10 7 cells/ml in DMEM medium to which [35S]-methionine/cysteine (Perkin Elmer, Wellesley, MA, USA) had been added to a final concentration of 200 pCi/ml, and pulsed for 1 h at 37°C. The pulse was stopped by centrifugation, washing the cells twice in RPMI-1640 (Gibco-BRL), and finally resuspending the cells in RPMI-1640 (Gibco-BRL) containing 10% dialyzed FCS at a concentration of 2 ϫ 10 7 cells/ml. After incubation for 3 h at 37°C, the cells were pelleted by centrifugation and resuspended to 10 7 cells/ml in lysis buffer [PBS/1% Triton X-100/1 M NaCl, 1 mM PMSF (Sigma Chemical), 200 KIE/ml aprotinin (Trasylol; Bayer, Leverkusen, Germany), 100 mg/ml leupeptin (Sigma Chemical), 1 mM EGTA, 200 mM GlcNac (Sigma Chemical), and 1 mM PMSF], 200 KIE/ml aprotinin, 100 mg/ml leupeptin (Sigma Chemical), and 1 mM EGTA were added to the cell medium. The lysate were incubated overnight at 4°C, and undissolved material was pelleted by centrifugation for 30 min at 11,000 g.
Immunoprecipitation
Affinity-purified rabbit antibodies against ficolin-1, gelatinase, NGAL, and MPO, were coupled to CNBr-activated Sepharose 48 (Pharmacia). Before use, unspecific protein binding sites present on the Sepharose beads were blocked by incubating overnight with 5% Tween-20 in 10 mM HEPES pH 7.4, 100 mM KC1. To further avoid unspecific binding, the lysate was initially precipitated with 50 l of rabbit IgG Sepharose beads for 2 h at 4°C. Immunoprecipitation was performed by adding 50 l IgG coupled Sepharose beads, incubating at 4°C for 2 h followed by centrifugation, and washing of the Sepharose particles 4 times in lysis buffer and finally twice in PBS. The lysate was precipitated with Sepharose-bound antibody in the following order: ficolin-1, gelatinase, NGAL, and MPO. The immunoprecipitated proteins were subjected to sodium dodecyl sulfate-PAGE (SDS-PAGE) by boiling the Sepharose particles in 30 l Laemmli buffer, and electrophoresis on 12% polyacrylamide gels under reducing conditions. The gels were stained using Coomassie blue, destained, submerged in Amplify (Amersham International, Amersham, Little Chalfont, Buckinghamshire, UK) for 1 h and dried in a Bio-Rad gel dryer (Bio-Rad). Molecular weight markers were identified and marked with traces of 35 S-methionin/ cysteine. The gels were placed in a Fuji BAS cassette (Fuji Film, Tokyo, Japan), exposed for 18 h at room temperature and developed by a Fuji BAS2500 PhosphorImager.
RESULTS
A polyclonal rabbit antibody against recombinant human ficolin-1 was generated and used for probing the subcellular localization of ficolin-1 in human neutrophils. A single band with molecular weight similar to the molecular weight of ficolin-1 was clearly visualized in the postnuclear supernatant of disrupted human neutrophils (S 1 ), indicating that the antibody was specific for ficolin-1 in neutrophils (Fig. 1A) . The immunoreactivity could be blocked by preincubation of the antibody with recombinant human ficolin-1 (data not shown). Recombinant ficolin-1 and ficolin-1 from neutrophils were visualized both under reducing and nonreducing conditions to verify the multipolymeric structure of the protein (Fig. 1, A and B ).
An ELISA for ficolin-1 was developed based on this antibody and used to determine the subcellular localization of ficolin-1 in human neutrophils. The distribution profiles of ficolin-1 in unstimulated neutrophils and in neutrophils stimulated with fMLP and PMA were compared with the distribution profiles of MPO, NGAL, gelatinase, HSA (human serum albumin), and HLA, representing marker proteins for azurophil granules, specific granules, gelatinase granules, secretory vesicles, and plasma membranes, respectively [17] . Figure 2 shows the distribution profile of MPO, NGAL, gelatinase, ficolin-1, HSA, and HLA in unstimulated neutrophils. It is readily observed that ficolin-1 is distributed in two peaks. The first and larger peak has its maximum in fraction 17 close to the peak of gelatinase in fraction 16, indicating that ficolin-1 is primarily located in gelatinase granules. However, the first peak of ficolin-1 is broader than the distribution of gelatinase, extending into higher numbered fractions. This indicates that some ficolin-1 is located in gelatinase-poor granules. The second and smaller peak colocalizes with the peak of HLA, suggesting that a minor amount of ficolin-1 is located on the surface of the plasma membrane. Notably, none of the peaks showed colocalization with albumin, the marker of secretory vesicles [31] . 7 neutrophils/ml disrupted by nitrogen cavitation. S 1 reveals a single band identical to the molecular weight of ficolin-1 under reducing conditions, indicating that the ficolin-1-antibody is specific for ficolin-1 in the neutrophils.
Flow cytometry was then performed to verify that ficolin-1 translocates from granules to the plasma membrane upon stimulation. Neutrophils were isolated and divided into two batches; one was kept unstimulated and one was stimulated with fMLP. Each batch was labeled with mouse IgG as a negative control, anti CD11b to verify stimulation, and anti-ficolin-1. A small amount of ficolin-1 was observed on the surface of unstimulated cells as compared with the negative control (Fig. 4A) , confirming the assumption that the second peak in the ficolin-1-distribution profile of unstimulated neutrophils represents ficolin-1 on the cell surface. When comparing ficolin-1 on the cell surface of unstimulated cells and cells stimulated with fMLP, a significant increase in the amount of the protein is observed on the surface of cells stimulated by fMLP (Fig. 4B) . This is in accordance with the interpretation that the increased amount of ficolin-1 in the second peak observed in Fig. 3A represents ficolin-1 associated with the plasma membrane. An increase in CD11b on the plasma membrane of neutrophils exposed to fMLP verifies that the stimulation was successful (Fig. 4C) .
To address whether binding of ficolin-1 to the surface membrane was dependent on binding sites appearing as a result of stimulation, stimulated and unstimulated neutrophils were incubated with r-ficolin-1 and subsequently labeled with anti-rficolin-1. No difference was observed between stimulated and unstimulated neutrophils in their ability to bind exogenously added ficolin-1 (Fig. 4D) . This indicates that binding of ficolin-1 to the cell membrane is not dependent on changes in the cell surface in response to stimulation. To exclude the possibility of an increased unspecific binding of antibodies in stimulated cells, binding of anti-HLA antibody to unstimulated neutrophils and to activated neutrophils, as well as binding of mouse IgG1-isotypes were analyzed. No difference in binding of antibody was observed between these two populations of cells (Fig. 4 , E and F). As a result of the fact that most of the ficolin-1 released from granules binds to the cell surface, measuring the total amount of ficolin-1 in stimulated and unstimulated cells could not quantitate the mobilization of ficolin-1 from granules. Instead, we estimated the mobilization of ficolin-1 from neutrophil granules by calculating the disappearance of ficolin-1 from the subcellular fractions, which contain granules. Observing the subcellular distributions of ficolin-1 in resting and stimulated neutrophils in Fig. 3A , we find it reasonable to assume that ficolin-1 in fraction 1 to 20 is associated with granules and ficolin-1 in fraction 21 to 35 is bound to the plasma membrane. On the basis of this assumption, we calculated the mobilization of ficolin-1 from granules upon stimulation with either fMLP or PMA ( Table 1) . Neutrophils stimulated with fMLP released 22% of gelatinase and 56% of ficolin-1.
In addition, we measured the amount of ficolin-1 in the S 0 subsequent to stimulation with fMLP to quantitate the release of ficolin-1 into the surrounding medium. Figure 5 illustrates the amount of gelatinase, HSA and ficolin-1 in lysate and S 0 from unstimulated neutrophils and neutrophils stimulated with fMLP expressed as percentages. The releases of gelatinase and HSA into S 0 upon stimulation were 25% and 71%, respec- tively. Whereas the release of gelatinase and HSA in resting neutrophils were 0.3% and 2%, respectively. The release of ficolin-1 into S 0 was only 4% compared with the total granule release of 56% in response to stimulation with fMLP, indicating that more than 90% of ficolin-1 mobilized upon stimulation associates with the cell surface of the neutrophil. The fact that the release of gelatinase and ficolin-1 from granules was 22% and 56%, respectively, indicates that ficolin-1 cannot be mobilized solely from the gelatinase-containing granules. This is in accordance with the difference in distribution profiles of the two proteins, where a significant part of ficolin-1 is localized in gelatinase poor granules. This indicates that ficolin-1 identifies a novel subset of neutrophil granules that is more extensively mobilized by stimulation than gelatinase granules which hitherto have been considered the most readily released granules of neutrophils [32, 33] .
Ficolins do not contain a membrane-spanning segment [11] and are not known to be membrane-integrated proteins. No receptor for ficolin-1 has been identified on the surface of eukaryotic cells. The mechanism by which exocytosed ficolin-1 binds to neutrophils is thus unknown. A Triton X-114 distribution profile of ficolin-1 was performed on a ␤-band from unstimulated neutrophils to study the hydrophobic properties of the protein. The material was obtained from a 2-layer Percoll gradient [20] and contains both specific granules and gelatinase granules [34] . hCAP18 and NGAL, which are present in specific granules [35, 36] , are known to be primarily hydrophobic and hydrophilic, respectively [37] . These could, therefore, serve as a control of the efficiency of the separation into a hydrophobic and a hydrophilic phase. NGAL is recovered in the hydrophilic phase, while ficolin-1 and hCAP18 are predominantly recovered in the hydrophobic phase (Fig. 6) , suggesting a possible binding to the surface membrane through interactions between lipid rafts and hydrophobic regions on ficolin-1. A low MW form of hCAP-18 corresponding with its hydrophilic cathelin part [38] distributes largely in the Triton X-114-poor phase. Data from the subcellular localization of ficolin-1 in unstimulated and stimulated neutrophils as presented in Figure 3 were used to calculate the release of ficolin-1 from granules assuming that Fractions 1-20 contain the ficolin-1 associated with granules, and Fractions 21-35 contain ficolin-1 bound to the surface membrane. Based on this assumption, we calculated total ficolin-1 release, membrane-bound ficolin-1 release, and ficolin-1 released to S 0 using the following equations. Immunohistochemistry of neutrophil granules was performed to supplement the localization of ficolin-1 as determined by subcellular fractionation. Slides containing neutrophils were stained with antibodies against ficolin-1 and the marker proteins gelatinase (gelatinase granules), hCAP18 (specific granules), and MPO (azurophil granules). Figure 7A shows close proximity of ficolin-1 (green fluorescence) and gelatinase (red fluorescence) resulting in yellow fluorescence, indicating a granular colocalization of these proteins. Figure 7 , B and C, demonstrates no significant granular colocalization between ficolin-1 and MPO or ficolin-1 and hCAP18.
According to the targeting-by-timing hypothesis, granule proteins synthesized at a given stage of maturation of the neutrophil precursor, will localized in the same subset of granules [18] . Neutrophil precursors were isolated from bone marrow and separated into three major stages on a two-layer Percoll gradient. The cells were depleted of nongranulocytic precursors and subjected to mRNA isolation and cDNA synthesis. Real-time TaqMan PCR was performed on each band for MPO, NGAL, gelatinase, and FCN1 and normalized to ␤-actin. Figure 8 shows mRNA expression profiles for MPO, NGAL, gelatinase and FCN1. On the basis of the targeting by timing hypothesis, FCN1 would be expected to have an expression profile similar to gelatinase, or an even higher relative expression of FCN1 in BC and SC. Surprisingly, this is not the case. The expression of FCN1-mRNA in MC and MM is 2.7 times higher than in BC and SC, compared with gelatinase-mRNA, which is 1.3 times higher in MC and MM than in BC and SC. Thus, the FCN1 expression profile resembles a profile in between the expression profiles of NGAL and gelatinase. To further explore this discrepancy between the FCN1 expression profile and the ficolin-1 distribution profile, we performed biosynthesis studies on neutrophil precursor cells from bone marrow. Figure 9 shows newly synthesized ficolin-1 and marker proteins in the cell lysate and chase medium of the three bands of bone marrow cells. The ratio between the intensity of band 1 and band 2 of the lysate was calculated for NGAL, gelatinase, and ficolin-1 (Fig. 10) . The ratio of gelatinase and NGAL were 1.72 and 0.54, respectively, indicating that band 1, as expected, had a relatively larger synthesis of gelatinase than NGAL compared with band 2. Ficolin-1 had a band 1/band 2 ratio of 0.73, showing a larger degree of synthesis of ficolin-1 in the MC/MM-stages compared with the BC/SG-stages However, the difference in synthesis of ficolin-1 between band 1 and band 2 was not as distinct as for the synthesis of gelatinase and NGAL. This supports the observation that the FCN1 mRNA expression profile lies between the profiles of gelatinase and NGAL.
Observing immunoprecipitated ficolin-1 from MB/PM cell lysate, a weak band can be seen, indicating a minor synthesis of ficolin-1 in the MB/PM stages, which is in accordance with the minor expression of FCN1 mRNA in band 3. A reason why the FCN1 mRNA expression profile and the ficolin-1 synthesis intensity is not reflected in the subcellular localization of ficolin-1 in mature neutrophils may be that the posttranslational travel of ficolin-1 through the ER and Golgi exceed the time period of MM/MC maturation, resulting in localization of ficolin-1 in granules synthesized at more mature cell stages, such as gelatinase granules.
DISCUSSION
The aim of this study was to identify the subcellular localization of ficolin-1 in human neutrophils. We found the protein present in gelatinase granules, but also in a hitherto unrecognized gelatinase poor subset of granules that is mobilized more extensively upon stimulation than gelatinase-rich granules. Determination of the mobilization from granules was complicated by the fact that the majority of ficolin-1 released from granules binds to the surface of neutrophils. We, therefore, analyzed the amount of ficolin-1 present in granules before and after stimulation by fMLP and PMA and used the data to estimate the mobilization from granules in response to stimulation. This clearly shows that ficolin-1 release from granules by fMLP stimulation is much more extensive than release of gelatinase. The release of 22% of total gelatinase by fMLP stimulation corresponds well with our previous observations [21] , yet Ͼ50% of granule-associated ficolin-1 is exocytosed from granules by fMLP stimulation. Since some ficolin-1 clearly colocalizes with gelatinase as observed both in the subcellular gradients and by immunohistochemistry, this ficolin-1 can be expected to mobilize along with gelatinase. However, a major part must be located in granules that are exocytosed to a much larger extent than gelatinase granules in response to fMLP. So far, only secretory vesicles have been shown to have such propensity for mobilization in response to chemotactic stimuli, such as fMLP [31, 39] . Secretory vesicles are created by endocytosis and contain and release plasma proteins. Secretory vesicles are not known to release any proteins synthesized by the neutrophils or their precursors [31, 40] . Albumin, which is the marker for secretory vesicles, has a distribution profile clearly distinct from the shoulder of ficolin-1 that does not colocalize with gelatinase. This indicates that this ficolin-1 marks a granule subset, which is more highly mobilized than gelatinase granules, and therefore, is highly relevant as a compartment, which harbors proteins such as ficolin-1 that must be released to the surroundings and not into the phagocytic vacuole.
The existence of such granule compartment is in agreement with our view on neutrophil granules, which we see as a continuum from the first formed and least mobilizable azurophil granules high in myeloperoxidase, to the last formed and most easily mobilized granules, which we hitherto considered to be gelatinase granules [17] . Within this continuum, granule subsets can be identified by additional markers, such as azurophil granule rich in defensins [41] , NGAL-rich granules with and without gelatinase [35] , and NGAL-containing granules with and without CRISP 3 [42] . The order in which the different subsets of granules are mobilized during extravasation is of major importance. During diapedesis of the neutrophils into to the perivascular tissue, secretory vesicles are completely mobilized, while 38% of gelatinase granules, 22% of specific granules, and 7% of azurophil granules are mobilized. Further stimulation of extravasated neutrophils may result in additional mobilization of neutrophil granules [32] . Keeping in mind the function of ficolin-1 as a soluble PRM in the lectin complement pathway, the localization of the protein in gelatinase granules, and in granules even more prone for exocytosis, seems important. Since ficolin-1 needs MASPs to initiate complement activation, it may be appropriate that ficolin-1-containing granules have a release profile quite similar to the plasma-containing secretory vesicles.
Neutrophils stimulated with 10 Ϫ8 M fMLP mobilize ϳ55%
of their content of ficolin-1, and more than 90% of the released ficolin-1 binds to the surface of the cells. Binding of ficolin-1 was also recently observed on monocytes [7] . The function and manner of this binding are so far unknown, as ficolin-1 lacks transmembrane domains, and since no ficolin-1 receptor has been identified. It is possible that the hydrophobic properties of ficolin-1 contribute to the surface binding. However, since the cell membrane of neutrophils contains acetylated carbohydrates and sialic acid, it is also possible that the C-terminal fibrinogen-like domain mediates binding of ficolin-1 to the surface. It has recently been demonstrated that hCAP-18 becomes associated with the surface of neutrophils after exocytosis from granules [43] , and it is known that proteinase 3 is associated with the surface membrane of neutrophils via the NB1 antigen [44, 45] . Human plasma contains 45-100 ng/ml of ficolin-1 [7] , which seems as a rather negligible amount compared with the serum concentrations of ficolin-2 and ficolin-3 of 1-12 g/ml and 3-50 g/ml, respectively [46, 47] . Monocytes secrete ficolin-1 constitutively and, in contrast to neutrophils, do not store the protein in granules. Monocytes release ϳ20 ng/10 6 cells over 4 days [7] , while neutrophils contain 10-30 ng/10 6 cells. As neutrophils outnumber monocytes by some 20-fold and have a much higher turnover rate, the contribution of ficolin-1 from monocytes must be negligible compared with the contribution from neutrophils. In addition, the synthesis of ficolin-1 ceases as monocytes mature to macrophage in tissues, whereas neutrophils predominantly mobilize their granule content after extravasation. Localization of ficolin-1 in highly mobilizable granules of neutrophils may provide a high local concentration of ficolin-1 at the site of microbial invasion, eliminating the need for a substantial level in plasma. The role of ficolin-1 in host defense still needs to be clarified. It was recently reported that a patient deficient in ficolin-3 suffered from recurrent warts, lung infections, and cerebral abscesses [48] ; however, no similar cases have been reported regarding ficolin-1. Several polymorphisms in the FCN1, FCN2, and FCN3 genes have been described, but only little is known about the functional role of these in disease development. Vander Cruyssen et al. [49] reported that certain polymorphism in the FCN1-gen is associated with susceptibly to developing rheumatoid arthritis. Another report by Schlapbach et al. [50] stated that infants with low ficolin-1 concentration in cord blood and suffering from NEC had a significantly higher risk of death compared with infants with normal concentration of ficolin-1 and suffering from NEC. However, the ability of ficolin-1 to associate with the surface of neutrophils may bring ficolin-1 into close proximity of invading microorganism in the perivascular tissue. It might be possible that the binding of ficolin-1 to the surface of microorganisms is more efficient, than the binding of ficolin-1 to the surface of neutrophils, which would result in detachment of ficolin-1 from the surface of the neutrophils and adhesion to the microorganisms in inflamed tissue.
